Publications by authors named "Hobin Lee"

The endogenous neuromodulator adenosine is massively released during hypoxic/ischemic insults and differentially modulates post-ischemic damage depending on the expression and recruitment of its four metabotropic receptor subtypes, namely A, A, A and A receptors (ARs, ARs, ARs and ARs). We previously demonstrated, by using a model of transient middle cerebral artery occlusion (tMCAo) in rats, that selective activation of ARs, as well as ARs, ameliorates post-ischemic brain damage in contrast to neuroinflammation. In the present study, we investigated whether the multitarget nucleoside MRS3997, a full agonist at both ARs and ARs, would afford higher neuroprotection in post-ischemic damage.

View Article and Find Full Text PDF

Lysophosphatidic acid receptor 1 (LPAR1) is an emerging therapeutic target for numerous human diseases including fibrosis. However, the limited number of available core structures of LPAR1 antagonists has prompted the need for novel chemical templates. In this study, we conducted a high-throughput virtual screening to discover potential new scaffolds.

View Article and Find Full Text PDF

Polo-like kinase 1 (Plk1) is considered an attractive target for anticancer therapy. Over the years, studies on the noncatalytic polo-box domain (PBD) of Plk1 have raised the expectation of generating highly specific protein-protein interaction inhibitors. However, the molecular nature of the canonical PBD-dependent interaction, which requires extensive water network-mediated interactions with its phospholigands, has hampered efforts to identify small molecules suitable for Plk1 PBD drug discovery.

View Article and Find Full Text PDF

In the tumor microenvironment, lysyl oxidase (LOX) is known to play a key role in stabilizing the tumor extracellular matrix. Here, we designed LOX-responsive nanoparticles to interact with the collagen matrix of the tumor microenvironment. Collagen-coated and imiquimod-loaded polydopamine nanoparticles (CPN/IQ) could form crosslinked structures with the collagen matrix via LOX.

View Article and Find Full Text PDF

Polo-like kinase 1 (Plk1), a mitotic kinase whose activity is widely upregulated in various human cancers, is considered an attractive target for anticancer drug discovery. Aside from the kinase domain, the C-terminal noncatalytic polo-box domain (PBD), which mediates the interaction with the enzyme's binding targets or substrates, has emerged as an alternative target for developing a new class of inhibitors. Various reported small molecule PBD inhibitors exhibit poor cellular efficacy and/or selectivity.

View Article and Find Full Text PDF

Adenosine receptor (AR) ligands are being developed for metabolic, cardiovascular, neurological, and inflammatory diseases and cancer. The ease of drug discovery is contingent on the availability of pharmacological tools. Fluorescent antagonist ligands for the human A and AARs were synthesized using two validated pharmacophores, 1,3-dipropyl-8-phenylxanthine and triazolo[1,5-c]quinazolin-5-yl)amine, which were coupled to eight reporter fluorophores: AlexaFluor, JaneliaFluor (JF), cyanine, and near infrared (NIR) dyes.

View Article and Find Full Text PDF
Article Synopsis
  • * These vesicles retain the functions of their original cells, allowing them to address challenges in drug delivery more effectively than synthetic alternatives.
  • * The review explores methods for producing these vesicles, their applications in treatment, and the potential for hybrid membranes from different cell types to expand drug delivery options.
View Article and Find Full Text PDF

Background: Despite the many advantages of recombinant subunit vaccines, they have critical weaknesses that include a low efficacy for promoting cellular and humoral immune responses against antigens because of their poor immunogenicity, and a rapidly cleared properties as a result of proteolytic enzymes in the body. To circumvent these problems, we developed mannan-decorated inulin acetate microparticles (M-IA MPs) that functioned as carriers and adjuvants for immunization with the recombinant foot-and-mouth disease multi-epitope subunit vaccine (M5BT).

Methods: The M5BT-loaded M-IA MPs were obtained by a double-emulsion solvent-evaporation method.

View Article and Find Full Text PDF
Article Synopsis
  • Researchers aimed to develop a new type of pain relief medication by combining a TRPV1 antagonist and mu-opioid receptor affinity to enhance effectiveness while minimizing side effects.
  • They created and analyzed a set of compounds, identifying compound 49 as particularly effective in lab tests for dual activity against both TRPV1 and mu-opioid receptors.
  • In animal tests, compound 49 showed strong pain relief effects that were consistent with its designed function, suggesting it could lead to a new class of analgesics.
View Article and Find Full Text PDF

After the introduction of a ban on the use of antibiotic growth promoters (AGPs) for livestock, the feeding environment, including the composition of animal intestinal microbiota, has changed rapidly. We hypothesized that the microbial genomes have also been affected by this legal prohibition, and investigated an important member of the swine gut microbiota, Lactobacillus salivarius, with a pan-genomic approach. Here, we isolated 21 L.

View Article and Find Full Text PDF

Several barriers such as gastric pH, enzymatic degradation and rapid transit should be overcome to orally deliver antigens for taking up by epithelial microfold cells in Peyer's patches of small intestine. To solve the above mentioned problems, we designed pH-sensitive and mucoadhesive polymeric microparticles (MPs) prepared by double emulsion technique using cellulose acetate phthalate (CAP) to enhance immune response of foot-and-mouth disease (FMD) virus (FMDV) subunit vaccine. Thiolation of CAP improved mucoadhesive property of CAP to prolong the MPs transit time through the gastrointestinal tract.

View Article and Find Full Text PDF

A series of 2-substituted 6-t-butylpyridine and 4-t-butylphenyl C-region analogues of 2-(3-fluoro-4-methylsulfonamidophenyl)propanamides were investigated for hTRPV1 antagonism. The analysis of structure activity relationships indicated that the pyridine derivatives generally exhibited a little better antagonism than did the corresponding phenyl surrogates for most of the series. Among the compounds, compound 7 showed excellent antagonism toward capsaicin activation with K=0.

View Article and Find Full Text PDF
Article Synopsis
  • - Concerns have emerged about the safety of traditional inactivated foot-and-mouth disease (FMD) vaccines, leading to research on a safer alternative using recombinant protein technology.
  • - The study developed a chimeric recombinant protein called 5BT, which includes multiple B cell and T cell epitopes to enhance immunogenicity, and was further improved for stability by conjugating it with a membrane protein (BmpB).
  • - Immunization of mice with either 5BT or its conjugate B5BT produced strong immune responses, comparable to conventional vaccines, suggesting that this recombinant protein could serve as an effective alternative for FMD vaccination.
View Article and Find Full Text PDF
Article Synopsis
  • - External breast expansion using devices like BRAVA and EVERA for 12 weeks showed promising results for increasing breast vessel count, but not breast density, in a study involving 34 Asian women.
  • - The trial had 28 participants completing it without major side effects, highlighting the safety of external expansion methods as compared to traditional silicone implants, which some women reject.
  • - Statistically significant increases in breast volume were observed in both device groups, with the EVERA device showing slightly higher volume gains, suggesting potential effectiveness for breast augmentation in the target demographic.
View Article and Find Full Text PDF

Although there have been many attempts to produce ω-3 fatty acid-rich eggs using alpha-linolenic acid (ALA) that is a popular fatty acid in the poultry feed industry, only limited knowledge about the effects of ALA-enriched diets on chicken fecal microbiota is currently available. Herein we examined the changes in the fecal microbiota composition, egg quality traits and fatty acid composition of the egg yolks of laying hens fed ALA-rich flaxseed oil for 8 weeks. The animals fed the experimental diets that contained 0 % (group C), 0.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates how soluble RANKL (sRANKL) can enhance the differentiation of M cells, which are crucial for initiating mucosal immune responses by transporting antigens in the intestine.
  • Researchers engineered a strain of Lactococcus lactis to produce sRANKL and confirmed its effectiveness in promoting M cell development and immune responses in mice when administered orally.
  • The findings suggest that oral delivery of sRANKL could be a novel adjuvant strategy to improve the efficacy of oral vaccines by boosting the immune response at mucosal sites.
View Article and Find Full Text PDF

Background: Facial rejuvenation can be achieved using a variety of techniques. Since minimally invasive procedures for face lifting have become popular because of their convenience and short operating time, numerous minimally invasive surgical procedures have been developed. In this study, a nonabsorbable polypropylene mesh is introduced as a new face lifting instrument, with the nasolabial fold as the main target area.

View Article and Find Full Text PDF

δ-Catenin induces dendritic morphogenesis in several cells and it was reported that deletion of C-terminal 207 amino acid of δ-catenin completely abolished the dendritic morphogenesis. However, exact domain responsible for inducing dendritic morphogenesis in C-terminus of δ-catenin was not mapped. Here, we report that expression of ΔC47 (lacking 47 amino acid of C-terminus: 1-1200), ΔC77 (lacking 77 amino acid of C-terminus: 1-1170) deletion mutants of δ-catenin induced the dendritic morphogenesis of HEK293T and NIH3T3 cells as full-length δ-catenin did.

View Article and Find Full Text PDF

The Rejuran® is a new filler product made from purified polynucleotides. Here we present data from an animal study and a clinical trial to examine the durability, efficacy and safety of the Rejuran® on crow's feet. For the animal study, 25 mice were divided into three groups: Group 1 received phosphate buffered saline (PBS); Group 2 were treated with Yvoire®; and Group 3 were treated with Rejuran®.

View Article and Find Full Text PDF

Lichens are symbiotic organisms which produce distinct secondary metabolic products. In the present study, we tested the cytotoxic activity of 17 lichen species against several human cancer cells and further investigated the molecular mechanisms underlying their anti-cancer activity. We found that among 17 lichens species, F.

View Article and Find Full Text PDF

Formic acid was used for the nitrate reduction as a reductant in the presence of Pd:Cu/gamma-alumina catalysts. The surface characteristics of the bimetallic catalyst synthesized by wet impregnation were investigated by SEM, TEM-EDS. The metals were not distributed homogeneously on the surface of catalyst, although the total contents of both metals in particles agreed well with the theoretical values.

View Article and Find Full Text PDF

A series of carbonate analogues of 5'-halogenated RTX have been investigated in order to examine the effect of the carbonate group as a linker and the role of halogens in the reversal of activity from agonism to antagonism for rat and human TRPV1 heterologously expressed in Chinese hamster ovary cells. The carbonate analogues showed similar activities to the corresponding RTX derivatives in rat TRPV1 but lower potency in human TRPV1. 5-Halogenation converted the agonists to partial agonists or full antagonists and the extent of antagonism reflected the order of I>Br>Cl>F, with a somewhat greater extent of antagonism for the derivatives of the 4-amino RTX surrogates compared to the corresponding derivatives of RTX itself.

View Article and Find Full Text PDF